Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Sosnowiec – page 61

1 193 clinical trials in Sosnowiec, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Sosnowiec at a glance
1 193
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

1 193 trials in Sosnowiec

Open in trial search

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Study on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not recruiting

Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Study on Tofacitinib for Patients with Early Active Axial Spondyloarthritis Who Did Not Respond to NSAIDs

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Naproxen
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Systemic Lupus Erythematosus

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol Myers Squibb International Corporation

Multiple sclerosis

Not recruiting

Study Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Methylprednisolone
  • Sponsor:Celltrion Inc.

Androgenetic alopecia

Not recruiting

Study on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Clascoterone
  • Sponsor:Cassiopea S.p.A.

Breast cancer

Not recruiting

Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Asthma

Not recruiting

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Desoximetasone
  • Sponsor:Medac Gesellschaft fuer klinische Spezialpraeparate mbH

Migraine

Not recruiting

Study on Botulinum Toxin Type A for Preventing Episodic Migraine in Adults

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:Ipsen Innovation

Migraine

Not recruiting

Study on Botulinum Toxin Type A for Preventing Chronic Migraine in Adults

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:Ipsen Innovation

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Sosnowiec

What the registry says about research in the country

01 Respiratory Diseases

Innovative clinical trials focusing on chronic obstructive pulmonary disease (COPD) and asthma management, testing new inhaler formulations and investigating treatments for respiratory conditions including respiratory syncytial virus (RSV).

  • COPD Treatment Optimization
  • Asthma Management
  • Respiratory Infections

Studies include evaluation of triple therapy combinations and novel propellant technologies for improved drug delivery.

02 Dermatological Conditions

Research examining treatments for various skin conditions, including atopic dermatitis, psoriasis, and hidradenitis suppurativa, with particular focus on innovative biological therapies.

  • Inflammatory Skin Diseases
  • Pediatric Dermatology
  • Chronic Skin Conditions

Clinical investigations include both adult and pediatric populations, testing new targeted therapies.

03 Gastrointestinal Disorders

Studies evaluating treatments for inflammatory bowel conditions, particularly Crohn's disease and ulcerative colitis, testing novel therapeutic approaches for disease management.

  • Inflammatory Bowel Disease
  • Long-term Disease Management
  • Novel Therapeutic Approaches

Focus on both induction and maintenance therapy for moderate to severe disease states.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.